Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Bullboard Posts
Comment by snuff69on Nov 12, 2018 9:50am
213 Views
Post# 28959059

RE:Pleasant surprize regarding St-Michael's Hospital jumping in

RE:Pleasant surprize regarding St-Michael's Hospital jumping inHere’s the letter from george
Dear Friend,
 
I have attached todays news release.  Here is some background:
 
1. Dr. Howard Leong-Poi and Dr. Chi-Ming Chow are very keen to use the VMS+ everyday on all patients.  They know the American, European and Canadian Guidelines for echocardiography call for a volumetric assessments of the heart at every visit and for the first time, they can actually follow the guidelines for standard of care.
2. More importantly, they will go forward and validate that this information is necessary to achieve the best outcome for their patients and will be publishing their results to make other cardiologists aware of the power of the information in diagnoses and monitoring heart diseases of all kinds.
3. Since St. Michael’s Hospital is "just around the corner”, we will have the VMS+ installed and examining patients very quickly.
4. This is now the fourth top-tier cardiac centre which will be using the VMS+.  We have other’s who are also close to buying the VMS+ and we will be announcing them as we receive the orders.
 
Thanks for your continued interest and support,

George Adams, PhD, ICD.D

Bullboard Posts